Alexion Pharmaceuticals, Inc. · 8 hours ago
Executive Director, AI Enterprise Process & Innovation
Gaithersburg, Maryland, United States of America
Full-time
Hybrid
Director/Executive
$250K/yr - $374K/yrAlexion Pharmaceuticals, Inc. is focused on delivering therapies to patients through innovative approaches. They are seeking an Executive Director for AI Enterprise Process & Innovation to lead the redesign of enterprise processes, embed AI into workflows, and drive cross-functional collaboration for improved business outcomes.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Redesign critical end-to-end processes to move from functionally optimized workflows to decision-centric models
Act as a cross-functional integrator by incubating and scaling AI-enabled use cases across functions
Partner with senior leaders to compose problem statements, outline benefit scenarios, and align AI solutions with business outcomes
Collaborate alongside Finance and enterprise leaders to develop metrics, track benefits, and confirm return on investment
Advise on areas where AI impacts operating leverage compared to where traditional optimization meets needs
Collaborate with AI, data, technology, risk, quality, and legal/compliance teams to ensure solutions are scalable, secure, compliant, and ethical
Codify governance that speeds delivery without compromising safety or trust
Lead adoption using innovative operational methods
Redefine roles and improve decision-making accountability
Build enterprise understanding of AI through leadership narratives, education, and hands-on engagement
Develop talent and communities of practice passionate about process innovation, AI product thinking, and system development
Plan effectively for succession
Lead or coordinate complex, high-value AI-enabled business improvement initiatives
Orchestrate cross-functional squads to remove blockers and embed AI into daily operations
Socialize strategic outcomes by demonstrating cost, quality, and financial improvements
Qualification
Required
Lead the redesign of important enterprise processes across the entire workflow
Transition from workflows optimized for functionality to AI-enabled, decision-focused operating models
Identify structural bottlenecks, manual handoffs, and slow decision points
Build intelligence into workflows rather than layering additional tools
Serve as an integrator across functions by connecting business, technology, data, and change capabilities to achieve enterprise-wide innovation
Incubate and expand AI-enabled use cases in areas such as R&D, Manufacturing, Quality, Commercial, Medical, Legal, Finance, and Procurement
Develop repeatable methods to progress ideas from pilot to broad organizational capability
Operate as a strategic internal consultancy to senior business leaders, shaping problem statements, defining value cases, and aligning AI solutions to business outcomes
Partner with Finance and business owners to define clear value metrics, track benefits realization and ROI, and ensure sustained impact
Advise executives on where AI can change operating leverage vs. where traditional optimization is sufficient
Partner with Enterprise AI, Data, IT, Risk, Quality, Legal/Compliance to ensure AI solutions are scalable, secure, compliant, and ethically deployed
Drive adoption through new ways of working, role redesign, and decision accountability—not just technology deployment
Build enterprise understanding of AI's role in process transformation via executive storytelling, education, and hands-on engagement
Develop talent and communities of practice committed to process innovation, AI product thinking, and architectural planning
Prepare thoughtfully for leadership continuity
Lead or oversee the most complex and crucial AI enabled Business Improvement initiatives to improve quality, effectiveness, and efficiency of business processes
Orchestrate cross functional squads to remove blockers and embed AI capabilities into day to day operations
Share strategic outcomes of key projects, outlining benefits from cost and quality perspectives and demonstrating the function's return on investment (ROI)
Preferred
Proven track record leading enterprise-scale AI-driven process transformation in complex, regulated environments
Executive-level advisory experience, turning ambiguous problems into clear value cases and operating leverage
Deep expertise in decision-centric operating models, process engineering, and systems design; familiarity with Lean, Six Sigma, or similar approaches
Proficiency in AI product thinking, ML engineering and MLOps, large language models and orchestration, and data platform integration
Experience establishing governance for responsible, secure AI in partnership with risk, quality, and legal/compliance functions
Strong storytelling and education skills to engage senior leaders and mobilize groups of expertise; demonstrated succession planning and talent development
Ability to orchestrate cross-functional squads and deliver from idea to pilot to scaled capability with measurable ROI
Comfort setting direction in early-stage, ambiguous environments through experimentation and rapid learning
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Founded in 1992
1001-5000 employees
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase